SD Plasma
Estimated value
£200k
Awarded value
£200k
Awarded 05 Mar 2019
Suppliers
1
Lots
1
1 awarded
Published
05 Aug 2019
Deadline 01 Mar 2019
Description
Supply of octaplas.
Scope
- Reference
- 02194
- Total value
- £200,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2019 to 30 Mar 2020
- CPV classifications
- 33100000
Submission & procedure
- Submission deadline
- 01 Mar 2019, 12:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£200k
Award date
05 Mar 2019
Contract start
31 Mar 2019
Contract end
30 Mar 2020
Awarded to
Awarded suppliers· 1 supplier
Awarded 05 Mar 2019 · Contract period 31 Mar 2019 — 30 Mar 2020
Award value
£200k
Other contracts from BIRMINGHAM CHILDREN'S HOSPITAL NHS FOUNDATION TRUST
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to OCTAPHARMA LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £72k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| Octapharma Ltd - Octaplas LG | contract | £53k | 14 Jun 2023 |
| Octaplex Treatment | contract | £100k | 10 May 2023 |
| Blood product required for the treatment of TTP patients | contract | £98k | 03 Aug 2022 |
| NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B | contract | — | 04 Jul 2022 |
| Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | £64.3m | 23 Jul 2021 |
| NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | — | 22 Jul 2021 |